 | • レポートコード：QAF27738 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の吸入＆点鼻薬ジェネリック医薬品市場について種類別（コルチコステロイド、気管支拡張剤、併用療法、鼻腔拡張剤スプレー、その他）、用途別（喘息、COPD、アレルギー性鼻炎、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・吸入＆点鼻薬ジェネリック医薬品市場の概要 ・世界の主要地域別吸入＆点鼻薬ジェネリック医薬品市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の吸入＆点鼻薬ジェネリック医薬品市場規模2016-2021：種類別（コルチコステロイド、気管支拡張剤、併用療法、鼻腔拡張剤スプレー、その他） ・世界の吸入＆点鼻薬ジェネリック医薬品市場予測2012-2027：種類別（コルチコステロイド、気管支拡張剤、併用療法、鼻腔拡張剤スプレー、その他） ・世界の吸入＆点鼻薬ジェネリック医薬品市場規模2016-2021：用途別（喘息、COPD、アレルギー性鼻炎、その他） ・世界の吸入＆点鼻薬ジェネリック医薬品市場予測2012-2027：用途別（喘息、COPD、アレルギー性鼻炎、その他） ・吸入＆点鼻薬ジェネリック医薬品のアメリカ市場規模と予測2016-2021 ・吸入＆点鼻薬ジェネリック医薬品のヨーロッパ市場規模と予測2016-2021 ・吸入＆点鼻薬ジェネリック医薬品の中国市場規模と予測2016-2021 ・吸入＆点鼻薬ジェネリック医薬品の日本市場規模と予測2016-2021 ・吸入＆点鼻薬ジェネリック医薬品の東南アジア市場規模と予測2016-2021 ・吸入＆点鼻薬ジェネリック医薬品のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Sandoz (Novartis AG)、Mylan、Allergan PLC、Cipla、Akorn、Apotex、Sun Pharma (Ranbaxy)、Nephron Pharma、Beximco Pharma、Hikma (Roxane)、XIANJU PHARMA） ・吸入＆点鼻薬ジェネリック医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・吸入＆点鼻薬ジェネリック医薬品の市場動向・機会・課題 ・調査の結論 |
Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies.
Market competition is intense among the top 4. The sales of generic inhalers and nasal sprays is expected to increase even further after the release of studies that point to an increase in the number of patients suffering from restrictive and even life-threatening respiratory diseases, such as COPD and asthma. The incredibly high healthcare costs, especially in developed economies, is therefore driving this growing patient pool towards generic drugs.
Market Analysis and Insights: Global Inhalation & Nasal Spray Generic Drugs Market
The global Inhalation & Nasal Spray Generic Drugs market was valued at US$ 10010 in 2020 and will reach US$ 14440 million by the end of 2027, growing at a CAGR of 6.3% during 2022-2027.
Global Inhalation & Nasal Spray Generic Drugs Scope and Market Size
The global Inhalation & Nasal Spray Generic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation & Nasal Spray Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Corticosteroids
Bronchodilators
Combinations
Decongestant Sprays
Others
Segment by Application
Asthma
COPD
Allergic Rhinitis
Others
The Inhalation & Nasal Spray Generic Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Inhalation & Nasal Spray Generic Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Sandoz (Novartis AG)
Mylan
Allergan PLC
Cipla
Akorn
Apotex
Sun Pharma (Ranbaxy)
Nephron Pharma
Beximco Pharma
Hikma (Roxane)
XIANJU PHARMA
1 Inhalation & Nasal Spray Generic Drugs Market Overview
1.1 Inhalation & Nasal Spray Generic Drugs Product Scope
1.2 Inhalation & Nasal Spray Generic Drugs Segment by Type
1.2.1 Global Inhalation & Nasal Spray Generic Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Corticosteroids
1.2.3 Bronchodilators
1.2.4 Combinations
1.2.5 Decongestant Sprays
1.2.6 Others
1.3 Inhalation & Nasal Spray Generic Drugs Segment by Application
1.3.1 Global Inhalation & Nasal Spray Generic Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Allergic Rhinitis
1.3.5 Others
1.4 Inhalation & Nasal Spray Generic Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Inhalation & Nasal Spray Generic Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Inhalation & Nasal Spray Generic Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Inhalation & Nasal Spray Generic Drugs Price Trends (2016-2027)
2 Inhalation & Nasal Spray Generic Drugs Estimates and Forecasts by Region
2.1 Global Inhalation & Nasal Spray Generic Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Inhalation & Nasal Spray Generic Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Inhalation & Nasal Spray Generic Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Inhalation & Nasal Spray Generic Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
2.4.3 China Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
2.4.6 India Inhalation & Nasal Spray Generic Drugs Estimates and Projections (2016-2027)
3 Global Inhalation & Nasal Spray Generic Drugs Competition Landscape by Players
3.1 Global Top Inhalation & Nasal Spray Generic Drugs Players by Sales (2016-2021)
3.2 Global Top Inhalation & Nasal Spray Generic Drugs Players by Revenue (2016-2021)
3.3 Global Inhalation & Nasal Spray Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhalation & Nasal Spray Generic Drugs as of 2020)
3.4 Global Inhalation & Nasal Spray Generic Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Inhalation & Nasal Spray Generic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Inhalation & Nasal Spray Generic Drugs Market Size by Type
4.1 Global Inhalation & Nasal Spray Generic Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Inhalation & Nasal Spray Generic Drugs Price by Type (2016-2021)
4.2 Global Inhalation & Nasal Spray Generic Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Inhalation & Nasal Spray Generic Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Inhalation & Nasal Spray Generic Drugs Price Forecast by Type (2022-2027)
5 Global Inhalation & Nasal Spray Generic Drugs Market Size by Application
5.1 Global Inhalation & Nasal Spray Generic Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Inhalation & Nasal Spray Generic Drugs Price by Application (2016-2021)
5.2 Global Inhalation & Nasal Spray Generic Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Inhalation & Nasal Spray Generic Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Inhalation & Nasal Spray Generic Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Inhalation & Nasal Spray Generic Drugs Price Forecast by Application (2022-2027)
6 North America Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
6.1 North America Inhalation & Nasal Spray Generic Drugs Sales by Company
6.1.1 North America Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
6.1.2 North America Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
6.2 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
6.2.1 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
6.3.1 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application (2022-2027)
7 Europe Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
7.1 Europe Inhalation & Nasal Spray Generic Drugs Sales by Company
7.1.1 Europe Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
7.1.2 Europe Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
7.2 Europe Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
7.2.1 Europe Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
8.1 China Inhalation & Nasal Spray Generic Drugs Sales by Company
8.1.1 China Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
8.1.2 China Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
8.2 China Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
8.2.1 China Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
8.3 China Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
9.1 Japan Inhalation & Nasal Spray Generic Drugs Sales by Company
9.1.1 Japan Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
9.1.2 Japan Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
9.2 Japan Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
9.2.1 Japan Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
10.1 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Company
10.1.1 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Inhalation & Nasal Spray Generic Drugs Market Facts & Figures
11.1 India Inhalation & Nasal Spray Generic Drugs Sales by Company
11.1.1 India Inhalation & Nasal Spray Generic Drugs Sales by Company (2016-2021)
11.1.2 India Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021)
11.2 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type
11.2.1 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Type (2022-2027)
11.3 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application
11.3.1 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Inhalation & Nasal Spray Generic Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Inhalation & Nasal Spray Generic Drugs Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Inhalation & Nasal Spray Generic Drugs Products Offered
12.1.5 Teva Recent Development
12.2 Sandoz (Novartis AG)
12.2.1 Sandoz (Novartis AG) Corporation Information
12.2.2 Sandoz (Novartis AG) Business Overview
12.2.3 Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Products Offered
12.2.5 Sandoz (Novartis AG) Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Inhalation & Nasal Spray Generic Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 Allergan PLC
12.4.1 Allergan PLC Corporation Information
12.4.2 Allergan PLC Business Overview
12.4.3 Allergan PLC Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Allergan PLC Inhalation & Nasal Spray Generic Drugs Products Offered
12.4.5 Allergan PLC Recent Development
12.5 Cipla
12.5.1 Cipla Corporation Information
12.5.2 Cipla Business Overview
12.5.3 Cipla Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cipla Inhalation & Nasal Spray Generic Drugs Products Offered
12.5.5 Cipla Recent Development
12.6 Akorn
12.6.1 Akorn Corporation Information
12.6.2 Akorn Business Overview
12.6.3 Akorn Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Akorn Inhalation & Nasal Spray Generic Drugs Products Offered
12.6.5 Akorn Recent Development
12.7 Apotex
12.7.1 Apotex Corporation Information
12.7.2 Apotex Business Overview
12.7.3 Apotex Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Apotex Inhalation & Nasal Spray Generic Drugs Products Offered
12.7.5 Apotex Recent Development
12.8 Sun Pharma (Ranbaxy)
12.8.1 Sun Pharma (Ranbaxy) Corporation Information
12.8.2 Sun Pharma (Ranbaxy) Business Overview
12.8.3 Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Products Offered
12.8.5 Sun Pharma (Ranbaxy) Recent Development
12.9 Nephron Pharma
12.9.1 Nephron Pharma Corporation Information
12.9.2 Nephron Pharma Business Overview
12.9.3 Nephron Pharma Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Nephron Pharma Inhalation & Nasal Spray Generic Drugs Products Offered
12.9.5 Nephron Pharma Recent Development
12.10 Beximco Pharma
12.10.1 Beximco Pharma Corporation Information
12.10.2 Beximco Pharma Business Overview
12.10.3 Beximco Pharma Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beximco Pharma Inhalation & Nasal Spray Generic Drugs Products Offered
12.10.5 Beximco Pharma Recent Development
12.11 Hikma (Roxane)
12.11.1 Hikma (Roxane) Corporation Information
12.11.2 Hikma (Roxane) Business Overview
12.11.3 Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Products Offered
12.11.5 Hikma (Roxane) Recent Development
12.12 XIANJU PHARMA
12.12.1 XIANJU PHARMA Corporation Information
12.12.2 XIANJU PHARMA Business Overview
12.12.3 XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Products Offered
12.12.5 XIANJU PHARMA Recent Development
13 Inhalation & Nasal Spray Generic Drugs Manufacturing Cost Analysis
13.1 Inhalation & Nasal Spray Generic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Inhalation & Nasal Spray Generic Drugs
13.4 Inhalation & Nasal Spray Generic Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Inhalation & Nasal Spray Generic Drugs Distributors List
14.3 Inhalation & Nasal Spray Generic Drugs Customers
15 Market Dynamics
15.1 Inhalation & Nasal Spray Generic Drugs Market Trends
15.2 Inhalation & Nasal Spray Generic Drugs Drivers
15.3 Inhalation & Nasal Spray Generic Drugs Market Challenges
15.4 Inhalation & Nasal Spray Generic Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Inhalation & Nasal Spray Generic Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Inhalation & Nasal Spray Generic Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Inhalation & Nasal Spray Generic Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Region (2016-2021)
Table 5. Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Region (2016-2021)
Table 8. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Inhalation & Nasal Spray Generic Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Inhalation & Nasal Spray Generic Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Inhalation & Nasal Spray Generic Drugs Sales Share by Company (2016-2021)
Table 14. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Company (2016-2021)
Table 16. Global Inhalation & Nasal Spray Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalation & Nasal Spray Generic Drugs as of 2020)
Table 17. Global Inhalation & Nasal Spray Generic Drugs Average Price (USD/K Units) of Key Company (2016-2021)
Table 18. Manufacturers Inhalation & Nasal Spray Generic Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Inhalation & Nasal Spray Generic Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Type (2016-2021)
Table 22. Global Inhalation & Nasal Spray Generic Drugs Sales Share by Type (2016-2021)
Table 23. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Inhalation & Nasal Spray Generic Drugs Price (USD/K Units) by Type (2016-2021)
Table 25. Global Inhalation & Nasal Spray Generic Drugs Sales Share by Type (2022-2027)
Table 26. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Type (2022-2027)
Table 28. Global Inhalation & Nasal Spray Generic Drugs Price (USD/K Units) by Type (2022-2027)
Table 29. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Application (2016-2021)
Table 30. Global Inhalation & Nasal Spray Generic Drugs Sales Share by Application (2016-2021)
Table 31. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Inhalation & Nasal Spray Generic Drugs Price (USD/K Units) by Application (2016-2021)
Table 33. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Application (2022-2027)
Table 34. Global Inhalation & Nasal Spray Generic Drugs Sales Share by Application (2022-2027)
Table 35. Global Inhalation & Nasal Spray Generic Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Application (2022-2027)
Table 37. Global Inhalation & Nasal Spray Generic Drugs Price (USD/K Units) by Application (2022-2027)
Table 38. North America Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 39. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 43. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 45. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 47. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 49. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 51. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 55. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 57. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 59. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 61. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 62. China Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 63. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 64. China Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 67. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 68. China Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 69. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 70. China Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 71. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 72. China Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 73. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 75. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 79. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 81. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 83. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 85. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 98. India Inhalation & Nasal Spray Generic Drugs Sales (M Units) by Company (2016-2021)
Table 99. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Company (2016-2021)
Table 100. India Inhalation & Nasal Spray Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Inhalation & Nasal Spray Generic Drugs Sales by Type (2016-2021) & (M Units)
Table 103. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2016-2021)
Table 104. India Inhalation & Nasal Spray Generic Drugs Sales by Type (2022-2027) & (M Units)
Table 105. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type (2022-2027)
Table 106. India Inhalation & Nasal Spray Generic Drugs Sales by Application (2016-2021) & (M Units)
Table 107. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2016-2021)
Table 108. India Inhalation & Nasal Spray Generic Drugs Sales by Application (2022-2027) & (M Units)
Table 109. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 113. Teva Inhalation & Nasal Spray Generic Drugs Product
Table 114. Teva Recent Development
Table 115. Sandoz (Novartis AG) Corporation Information
Table 116. Sandoz (Novartis AG) Description and Business Overview
Table 117. Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 118. Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Product
Table 119. Sandoz (Novartis AG) Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 123. Mylan Inhalation & Nasal Spray Generic Drugs Product
Table 124. Mylan Recent Development
Table 125. Allergan PLC Corporation Information
Table 126. Allergan PLC Description and Business Overview
Table 127. Allergan PLC Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 128. Allergan PLC Inhalation & Nasal Spray Generic Drugs Product
Table 129. Allergan PLC Recent Development
Table 130. Cipla Corporation Information
Table 131. Cipla Description and Business Overview
Table 132. Cipla Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 133. Cipla Inhalation & Nasal Spray Generic Drugs Product
Table 134. Cipla Recent Development
Table 135. Akorn Corporation Information
Table 136. Akorn Description and Business Overview
Table 137. Akorn Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 138. Akorn Inhalation & Nasal Spray Generic Drugs Product
Table 139. Akorn Recent Development
Table 140. Apotex Corporation Information
Table 141. Apotex Description and Business Overview
Table 142. Apotex Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 143. Apotex Inhalation & Nasal Spray Generic Drugs Product
Table 144. Apotex Recent Development
Table 145. Sun Pharma (Ranbaxy) Corporation Information
Table 146. Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 147. Sun Pharma (Ranbaxy) Description and Business Overview
Table 148. Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Product
Table 149. Sun Pharma (Ranbaxy) Recent Development
Table 150. Nephron Pharma Corporation Information
Table 151. Nephron Pharma Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 152. Nephron Pharma Description and Business Overview
Table 153. Nephron Pharma Inhalation & Nasal Spray Generic Drugs Product
Table 154. Nephron Pharma Recent Development
Table 155. Beximco Pharma Corporation Information
Table 156. Beximco Pharma Description and Business Overview
Table 157. Beximco Pharma Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 158. Beximco Pharma Inhalation & Nasal Spray Generic Drugs Product
Table 159. Beximco Pharma Recent Development
Table 160. Hikma (Roxane) Corporation Information
Table 161. Hikma (Roxane) Description and Business Overview
Table 162. Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 163. Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Product
Table 164. Hikma (Roxane) Recent Development
Table 165. XIANJU PHARMA Corporation Information
Table 166. XIANJU PHARMA Description and Business Overview
Table 167. XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 168. XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Product
Table 169. XIANJU PHARMA Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Inhalation & Nasal Spray Generic Drugs Distributors List
Table 173. Inhalation & Nasal Spray Generic Drugs Customers List
Table 174. Inhalation & Nasal Spray Generic Drugs Market Trends
Table 175. Inhalation & Nasal Spray Generic Drugs Market Drivers
Table 176. Inhalation & Nasal Spray Generic Drugs Market Challenges
Table 177. Inhalation & Nasal Spray Generic Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalation & Nasal Spray Generic Drugs Product Picture
Figure 2. Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Asthma Examples
Figure 7. COPD Examples
Figure 8. Allergic Rhinitis Examples
Figure 9. Others Examples
Figure 10. Global Inhalation & Nasal Spray Generic Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Inhalation & Nasal Spray Generic Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Inhalation & Nasal Spray Generic Drugs Sales (M Units) Growth Rate (2016-2027)
Figure 13. Global Inhalation & Nasal Spray Generic Drugs Price Trends Growth Rate (2016-2027) (USD/K Units)
Figure 14. Global Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Inhalation & Nasal Spray Generic Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Inhalation & Nasal Spray Generic Drugs Sales (M Units) Growth Rate (2016-2027)
Figure 18. Europe Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Inhalation & Nasal Spray Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Inhalation & Nasal Spray Generic Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Inhalation & Nasal Spray Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Inhalation & Nasal Spray Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Inhalation & Nasal Spray Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Inhalation & Nasal Spray Generic Drugs Players Market Share by Revenue in Inhalation & Nasal Spray Generic Drugs: 2016 & 2020
Figure 29. Inhalation & Nasal Spray Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Inhalation & Nasal Spray Generic Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Inhalation & Nasal Spray Generic Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Inhalation & Nasal Spray Generic Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 35. North America Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 36. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 37. Europe Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 38. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 39. China Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 40. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 41. Japan Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 44. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Type in 2020
Figure 45. India Inhalation & Nasal Spray Generic Drugs Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Inhalation & Nasal Spray Generic Drugs
Figure 48. Manufacturing Process Analysis of Inhalation & Nasal Spray Generic Drugs
Figure 49. Inhalation & Nasal Spray Generic Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界のオロパタジン点鼻スプレー市場規模・現状・予測（2021年-2027年） Olopatadine nasal spray is used to treat the symptoms of seasonal (short-term) allergic rhinitis (hay fever), such as sneezing, itchy or runny nose, or itchy eyes. Market Analysis and Insights: Global Olopatadine Nasal Spray Market The global Olopatadine Nasal Spray market size is projected to reach…- 鼻スプレーのグローバル市場調査 2019年 The global Nasal Spray market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nasal Spray volume and value at global level, regional level and company level. From a global perspective, this report represen…
- 世界の点鼻ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nasal Spray Vaccine Market The global Nasal Spray Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界の鼻ポリープ治療薬市場規模・現状・予測（2021年-2027年） Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
- 世界のジェネリック腫瘍薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Generic Oncology Drugs Market The global Generic Oncology Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…